Clinical Trials Logo

Clinical Trial Summary

This study observed the relationship between cerebral collateral circulation and the prognosis of leukoaraiosis in high-risk population. Cerebral collateral circulation and leukoaraiosis levels will be evaluated and followed up by magnetic resonance examination. The participants' clinical performance caused by leukoaraiosis will be assessed by a series of scales.


Clinical Trial Description

1. Case collection information is sent daily to clinical trial supervisors.

2. The clinical trial team meets once a week to monitor the quality of clinical trials.

3. The severity of the leukoaraiosis will be evaluated by a scale. The patients whose score is more than 2 will take additional magnetic resonance examination including magnetic resonance angiography (MRA) and arterial spin labeling (ASL). And their cognitive ability will be evaluated by a series of scales including Mini-Mental State Examination (MMSE) and Montreal cognitive assessment (MoCA) and gait by the short physical performance battery (SPPB).

The blood sample will be taken for biochemical detection and hair and nail samples for trace element detection.

4. Data were analyzed by regression analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03246373
Study type Observational [Patient Registry]
Source Shanghai Zhongshan Hospital
Contact Anyan Ge
Phone 862164041990
Email ge.anyan@zs-hospital.sh.cn
Status Recruiting
Phase
Start date October 11, 2017
Completion date December 30, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT06181981 - Leucoaraiosis and Multimodal MRI With Fingerprinting Technique
Recruiting NCT02761148 - The Relationship Between White Matter Hyperintensity With Cognition and Emotion N/A
Not yet recruiting NCT03903601 - Concentration of Trimethylamine Oxide (TMAO) in Blood Plasma as a Risk Factor for Vascular Cerebral Damage
Recruiting NCT05491980 - Florida Cerebrovascular Disease Biorepository and Genomics Center